Literature DB >> 2861879

Treating hay fever.

S T Holgate, P H Howarth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861879      PMCID: PMC1416253          DOI: 10.1136/bmj.291.6488.92

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

Review 1.  Mediators of nasal allergy.

Authors:  N Mygind
Journal:  J Allergy Clin Immunol       Date:  1982-09       Impact factor: 10.793

Review 2.  Topical steroid treatment for allergic rhinitis and allied conditions.

Authors:  N Mygind
Journal:  Clin Otolaryngol Allied Sci       Date:  1982-10

3.  Anaphylactic reaction to desensitisation for allergic rhinitis and asthma.

Authors:  D A Rands
Journal:  Br Med J       Date:  1980-09-27

4.  In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.

Authors:  P M Laduron; P F Janssen; W Gommeren; J E Leysen
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

5.  Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.

Authors:  P H Howarth; M B Emanuel; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

6.  Local nasal immunotherapy for ragweed-allergic rhinitis. III. A second year of treatment.

Authors:  J A Nickelsen; J W Georgitis; U R Mueller; J Kane; J I Wypych; S Goldstein; R E Reisman; C E Arbesman
Journal:  Clin Allergy       Date:  1983-11

7.  Clinical investigation of terfenadine, a non-sedating antihistamine.

Authors:  M L Brandon; M Weiner
Journal:  Ann Allergy       Date:  1980-02
  7 in total
  1 in total

Review 1.  Treatment of hay fever.

Authors:  S F Wood
Journal:  J R Coll Gen Pract       Date:  1989-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.